On the public citation graph

Use of Azithromycin and Death from Cardiovascular Causes

0 signed · 254 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/pds.1926openalex-snapshot
A basic study design for expedited safety signal evaluation based on electronic healthcare data
inferredcites →https://doi.org/10.1016/0002-9343(91)90401-iopenalex-snapshot
Clinical toleration and safety of azithromycin
inferredcites →https://doi.org/10.1056/nejmoa040582openalex-snapshot
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
inferredcites →https://doi.org/10.1056/nejmoa1003833openalex-snapshot
Azithromycin and the Risk of Cardiovascular Death
inferredcites →https://doi.org/10.1086/340861openalex-snapshot
Concomitant Risk Factors in Reports of Torsades de Pointes Associated with Macrolide Use: Review of the United States Food and Drug Administration Adverse Event Reporting System
inferredcites →https://doi.org/10.1086/508873openalex-snapshot
Antimicrobial-Associated QT Interval Prolongation: Pointes of Interest
inferredcites →https://doi.org/10.1093/eurheartj/ehi312openalex-snapshot
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
inferredcites →https://doi.org/10.1093/jac/48.5.677openalex-snapshot
Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections
inferredcites →https://doi.org/10.1097/ede.0b013e318212640copenalex-snapshot
Nonexperimental Comparative Effectiveness Research Using Linked Healthcare Databases
inferredcites →https://doi.org/10.1111/j.1742-7843.2006.pto_293.xopenalex-snapshot
Indications for Propensity Scores and Review of their Use in Pharmacoepidemiology
inferredcites →https://doi.org/10.1124/jpet.102.037911openalex-snapshot
Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes
inferredcites →https://doi.org/10.1177/1403494810387965openalex-snapshot
The Danish Civil Registration System
inferredcites →https://doi.org/10.1177/1403494810394717openalex-snapshot
The Danish National Prescription Registry
inferredcites →https://doi.org/10.1177/1403494811399958openalex-snapshot
The Danish Register of Causes of Death
inferredcites →https://doi.org/10.1177/1403494811401482openalex-snapshot
The Danish National Patient Register

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3863358openalex-extracted
A Benefit-Harm Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1001/jama.2013.280501openalex-snapshot
Oral Fluoroquinolone Use and Retinal Detachment
inferred← citeshttps://doi.org/10.1001/jama.2014.10176openalex-snapshot
Azithromycin for Elderly Patients With Pneumonia—Reply
inferred← citeshttps://doi.org/10.1001/jama.2014.4304openalex-snapshot
Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.16864openalex-snapshot
Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.8199openalex-snapshot
Association of Azithromycin Use With Cardiovascular Mortality
inferred← citeshttps://doi.org/10.1001/jamaophthalmol.2016.3477openalex-snapshot
Oral Fluoroquinolone Use and Retinal Detachment
inferred← citeshttps://doi.org/10.1002/14651858.cd011825openalex-snapshot
Adverse events in patients taking macrolide antibiotics versus placebo for any indication
inferred← citeshttps://doi.org/10.1002/14651858.cd011825.pub2openalex-snapshot
Adverse events in people taking macrolide antibiotics versus placebo for any indication
inferred← citeshttps://doi.org/10.1002/ctm2.549openalex-snapshot
Characterization of the molecular mechanisms underlying azithromycin‐induced cardiotoxicity using human‐induced pluripotent stem cell‐derived cardiomyocytes
inferred← citeshttps://doi.org/10.1002/jhm.2448openalex-snapshot
Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center
inferred← citeshttps://doi.org/10.1002/pds.3842openalex-snapshot
Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia
inferred← citeshttps://doi.org/10.1002/pds.5451openalex-snapshot
The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin–clavulanate in US Veterans
inferred← citeshttps://doi.org/10.1002/phar.1381openalex-snapshot
Evidence Behind FDA Alerts for Drugs with Adverse Cardiovascular Effects: Implications for Clinical Practice
inferred← citeshttps://doi.org/10.1002/phar.2270openalex-snapshot
The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients
inferred← citeshttps://doi.org/10.1002/phar.2343openalex-snapshot
Concomitant Use of Quinolones and Stimulants and the Risk of Adverse Cardiovascular Symptoms: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1002/phar.2355openalex-snapshot
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms
inferred← citeshttps://doi.org/10.1007/978-3-030-43435-9_10openalex-snapshot
Medication Safety in Chronic Lung Disease with Cardiac Comorbidity
inferred← citeshttps://doi.org/10.1007/978-3-319-72416-4_2openalex-snapshot
Macrolides, Azalides, and Ketolides
inferred← citeshttps://doi.org/10.1007/s00018-004-4035-xopenalex-snapshot
Hemokinins and endokinins
inferred← citeshttps://doi.org/10.1007/s00059-013-4035-4openalex-snapshot
Medikamentöse Therapie von Herz- und Lungenerkrankungen
inferred← citeshttps://doi.org/10.1007/s00210-026-05949-8openalex-snapshot
Cardiotoxicity of macrolide antibiotics: a pharmacovigilance study integrating FAERS and JADER databases
inferred← citeshttps://doi.org/10.1007/s00784-020-03314-4openalex-snapshot
Inhibition of neutrophil inflammatory mediator expression by azithromycin
inferred← citeshttps://doi.org/10.1007/s10096-019-03473-7openalex-snapshot
Macrolide prescription in Dutch children: compliance with guidelines
inferred← citeshttps://doi.org/10.1007/s11095-014-1382-7openalex-snapshot
Azithromycin Cationic Non-Lecithoid Nano/Microparticles Improve Bioavailability and Targeting Efficiency
inferred← citeshttps://doi.org/10.1007/s11739-024-03653-0openalex-snapshot
Low-dose azithromycin prophylaxis in patients with atrial fibrillation and chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1007/s11845-015-1372-8openalex-snapshot
Assessing potential risks of treatment with long-term azithromycin in COPD patients: long-term oxygen users beware?
inferred← citeshttps://doi.org/10.1007/s11908-015-0507-4openalex-snapshot
The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia
inferred← citeshttps://doi.org/10.1007/s12012-014-9289-4openalex-snapshot
Azithromycin Can Prolong QT Interval and Suppress Ventricular Contraction, but Will Not Induce Torsade de Pointes
inferred← citeshttps://doi.org/10.1007/s12012-017-9401-7openalex-snapshot
Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin
inferred← citeshttps://doi.org/10.1007/s13181-020-00777-5openalex-snapshot
COVID-19: Therapeutics and Their Toxicities
inferred← citeshttps://doi.org/10.1007/s13312-019-1633-0openalex-snapshot
Mass Administration of Azithromycin to Prevent Pre-school Childhood Mortality: Boon or Bane?
inferred← citeshttps://doi.org/10.1007/s13665-013-0062-0openalex-snapshot
Management of community-acquired pneumonia
inferred← citeshttps://doi.org/10.1007/s40138-016-0107-0openalex-snapshot
Controversies in the Management of Community-Acquired Pneumonia
inferred← citeshttps://doi.org/10.1007/s40264-017-0533-2openalex-snapshot
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s40264-017-0539-9openalex-snapshot
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study
inferred← citeshttps://doi.org/10.1007/s40264-020-00976-7openalex-snapshot
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
inferred← citeshttps://doi.org/10.1007/s40266-018-0541-7openalex-snapshot
Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions
inferred← citeshttps://doi.org/10.1007/s40278-013-2880-9openalex-snapshot
Azithromycin and CV mortality risk in a general population
inferred← citeshttps://doi.org/10.1007/s40801-022-00300-yopenalex-snapshot
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
inferred← citeshttps://doi.org/10.1016/b978-0-12-821446-6.00007-9openalex-snapshot
Drug-induced torsades de pointes
inferred← citeshttps://doi.org/10.1016/b978-0-12-821446-6.00012-2openalex-snapshot
Antimicrobial agents and torsades de pointes
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00137-0openalex-snapshot
Legionnaires’ Disease, Pontiac Fever, and Related Illnesses
inferred← citeshttps://doi.org/10.1016/b978-0-444-63407-8.00026-5openalex-snapshot
Miscellaneous Antibacterial Drugs
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00067-9openalex-snapshot
Acute Exacerbations of Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00069-2openalex-snapshot
Acute Pneumonia
inferred← citeshttps://doi.org/10.1016/j.amjcard.2020.04.054openalex-snapshot
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019
inferred← citeshttps://doi.org/10.1016/j.amjcard.2023.11.069openalex-snapshot
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical Trials
inferred← citeshttps://doi.org/10.1016/j.amjmed.2015.07.032openalex-snapshot
Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly
inferred← citeshttps://doi.org/10.1016/j.arbres.2026.01.010openalex-snapshot
Macrolide-based Treatment and Long-term Outcomes in Community-acquired Pneumonia
inferred← citeshttps://doi.org/10.1016/j.cej.2022.135591openalex-snapshot
Architecting hierarchal Zn3V2O8/P-rGO nanostructure: Electrochemical determination of anti-viral drug azithromycin in biological samples using SPCE
inferred← citeshttps://doi.org/10.1016/j.cmi.2024.12.013openalex-snapshot
The risk of drug-induced liver injury associated with flucloxacillin: a nationwide, entropy-balanced cohort study
inferred← citeshttps://doi.org/10.1016/j.comtox.2019.02.002openalex-snapshot
From personalization to patient centered systems toxicology and pharmacology
inferred← citeshttps://doi.org/10.1016/j.cpcardiol.2021.100981openalex-snapshot
The Cardiac Effects of COVID-19: Review of articles
inferred← citeshttps://doi.org/10.1016/j.det.2016.02.009openalex-snapshot
Practice Gaps
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2014.01.013openalex-snapshot
Suppressive therapy using azithromycin in 2 rare cases of recurrent staphylococcal infections
inferred← citeshttps://doi.org/10.1016/j.ejim.2015.09.009openalex-snapshot
Association of macrolides with overall mortality and cardiac death among patients with various infections: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ejps.2015.05.009openalex-snapshot
The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides
inferred← citeshttps://doi.org/10.1016/j.iac.2019.12.005openalex-snapshot
The Role of Macrolides and Doxycycline in Chronic Rhinosinusitis
inferred← citeshttps://doi.org/10.1016/j.idnow.2023.01.003openalex-snapshot
A single dose of ciprofloxacin reduces the duration of diarrhea among service members deployed in Africa
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2020.106053openalex-snapshot
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
inferred← citeshttps://doi.org/10.1016/j.ijid.2013.07.005openalex-snapshot
Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia
inferred← citeshttps://doi.org/10.1016/j.jacadv.2024.101337openalex-snapshot
Azithromycin Exposure in a 10-Day Window of Myocardial Infarction and Short- and Long-Term Outcomes
inferred← citeshttps://doi.org/10.1016/j.jacc.2015.09.029openalex-snapshot
The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk
inferred← citeshttps://doi.org/10.1016/j.jaip.2014.06.002openalex-snapshot
The Role of Atypical Infections and Macrolide Therapy in Patients with Asthma
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2017.02.011openalex-snapshot
When is a null finding in register-based epidemiology convincing?
inferred← citeshttps://doi.org/10.1016/j.jelectrocard.2020.08.008openalex-snapshot
The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
inferred← citeshttps://doi.org/10.1016/j.jelectrocard.2022.11.008openalex-snapshot
Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilities
inferred← citeshttps://doi.org/10.1016/j.jpeds.2016.11.012openalex-snapshot
Cardiac Arrest in Pediatric Patients Receiving Azithromycin
inferred← citeshttps://doi.org/10.1016/j.jpp.2015.01.004openalex-snapshot
Conduite à tenir devant un ou plusieurs cas de coqueluche
inferred← citeshttps://doi.org/10.1016/j.kint.2022.05.024openalex-snapshot
Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure
inferred← citeshttps://doi.org/10.1016/j.lpm.2013.08.006openalex-snapshot
Macrolides au long cours et pathologie bronchique chronique de l’adulte : intérêts et limites
inferred← citeshttps://doi.org/10.1016/j.mayocp.2014.09.006openalex-snapshot
Non–anti-infective Effects of Antimicrobials and Their Clinical Applications
inferred← citeshttps://doi.org/10.1016/j.nurpra.2014.10.028openalex-snapshot
Cardiovascular Risks Associated With Azithromycin: Worth the Hype?
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2014.03.003openalex-snapshot
Azithromycin: Mechanisms of action and their relevance for clinical applications
inferred← citeshttps://doi.org/10.1016/j.psym.2017.10.009openalex-snapshot
QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update
inferred← citeshttps://doi.org/10.1016/j.pupt.2017.02.001openalex-snapshot
Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring?
inferred← citeshttps://doi.org/10.1016/j.resuscitation.2019.04.030openalex-snapshot
Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study
inferred← citeshttps://doi.org/10.1016/j.rmr.2014.12.003openalex-snapshot
Haut Conseil de la santé publique (HCSP). Conduite à tenir devant un ou plusieurs cas de coqueluche
inferred← citeshttps://doi.org/10.1016/j.ssci.2020.104842openalex-snapshot
Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations
inferred← citeshttps://doi.org/10.1016/j.tmaid.2019.02.006openalex-snapshot
Frequent medication combinations in travel medicine are associated with QTc prolongation
inferred← citeshttps://doi.org/10.1016/j.ypdi.2015.02.031openalex-snapshot
10.1016/j.ypdi.2015.02.031
inferred← citeshttps://doi.org/10.1016/s0084-3873(15)00257-6openalex-snapshot
10.1016/s0084-3873(15)00257-6
inferred← citeshttps://doi.org/10.1016/s0929-693x(13)71418-0openalex-snapshot
Rationnel ou irrationnel de l’utilisation de l’azithromycine
inferred← citeshttps://doi.org/10.1016/s2213-2600(14)70107-9openalex-snapshot
The role of macrolides in asthma: current evidence and future directions
inferred← citeshttps://doi.org/10.1016/s2213-2600(15)00518-4openalex-snapshot
Cardiac effects of current treatments of chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1016/s2213-2600(21)00263-0openalex-snapshot
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
inferred← citeshttps://doi.org/10.1017/9781108147972.011openalex-snapshot
Potential Roadblocks in Healthcare Big Data Collection
inferred← citeshttps://doi.org/10.1017/ash.2024.453openalex-snapshot
The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia
inferred← citeshttps://doi.org/10.1039/9781782623113-00206openalex-snapshot
Anti-Inflammatory Macrolides to Manage Chronic Neutrophilic Inflammation
inferred← citeshttps://doi.org/10.1056/jw201305010000001openalex-snapshot
Is Azithromycin Cardiotoxic
inferred← citeshttps://doi.org/10.1056/nejmc1306999openalex-snapshot
Cardiovascular Risks with Azithromycin
inferred← citeshttps://doi.org/10.1056/nejmc1401831openalex-snapshot
Lack of Association between Azithromycin and Death from Cardiovascular Causes
inferred← citeshttps://doi.org/10.1056/nejmoa1003833openalex-snapshot
Azithromycin and the Risk of Cardiovascular Death
inferred← citeshttps://doi.org/10.1056/nejmoa1602044openalex-snapshot
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
inferred← citeshttps://doi.org/10.1056/nejmoa1715474openalex-snapshot
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa
inferred← citeshttps://doi.org/10.1056/nejmoa1817213openalex-snapshot
Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa
inferred← citeshttps://doi.org/10.1056/nejmoa2212111openalex-snapshot
Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth
inferred← citeshttps://doi.org/10.1056/nejmp1302726openalex-snapshot
Cardiovascular Risks with Azithromycin and Other Antibacterial Drugs
inferred← citeshttps://doi.org/10.1080/00325481.2017.1285677openalex-snapshot
Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician
inferred← citeshttps://doi.org/10.1080/00325481.2017.1362938openalex-snapshot
Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review
inferred← citeshttps://doi.org/10.1080/14656566.2017.1340940openalex-snapshot
Pharmacotherapy for community-acquired pneumonia in the elderly
inferred← citeshttps://doi.org/10.1080/14740338.2021.1932814openalex-snapshot
The long-term safety of chronic azithromycin use in adult patients with cystic fibrosis, evaluating biomarkers for renal function, hepatic function and electrical properties of the heart
inferred← citeshttps://doi.org/10.1080/14787210.2016.1179580openalex-snapshot
Macrolides use and the risk of sudden cardiac death
inferred← citeshttps://doi.org/10.1080/15459624.2024.2405405openalex-snapshot
Preliminary human health risk assessment of antibiotic exposures in human waste handling occupations
inferred← citeshttps://doi.org/10.1093/aje/kwx359openalex-snapshot
Long-Term Risk of Cardiovascular Death With Use of Clarithromycin and Roxithromycin: A Nationwide Cohort Study
inferred← citeshttps://doi.org/10.1093/cid/ciab825openalex-snapshot
Oral Fluoroquinolone Use and the Risk of Acute Liver Injury: A Nationwide Cohort Study
inferred← citeshttps://doi.org/10.1093/cid/ciu914openalex-snapshot
Risks of Cardiac Arrhythmia and Mortality Among Patients Using New-Generation Macrolides, Fluoroquinolones, and β-Lactam/β-Lactamase Inhibitors: A Taiwanese Nationwide Study
inferred← citeshttps://doi.org/10.1093/eurheartj/ehz231openalex-snapshot
Duration and life-stage of antibiotic use and risk of cardiovascular events in women
inferred← citeshttps://doi.org/10.1093/europace/euaa288openalex-snapshot
Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs
inferred← citeshttps://doi.org/10.1093/europace/euab043openalex-snapshot
Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case
inferred← citeshttps://doi.org/10.1093/jac/dku159openalex-snapshot
Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1093/jac/dkz127openalex-snapshot
‘Warning: allergic to penicillin’: association between penicillin allergy status in 2.3 million NHS general practice electronic health records, antibiotic prescribing and health outcomes
inferred← citeshttps://doi.org/10.1093/jnci/djx267openalex-snapshot
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study
inferred← citeshttps://doi.org/10.1093/jnci/djy144openalex-snapshot
Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication
inferred← citeshttps://doi.org/10.1093/jtm/tay111openalex-snapshot
ECG abnormalities in a patient with paratyphoid fever
inferred← citeshttps://doi.org/10.1097/01.jaa.0000511033.34198.95openalex-snapshot
Is cardiovascular risk a concern when prescribing azithromycin?
inferred← citeshttps://doi.org/10.1097/aog.0000000000004473openalex-snapshot
A Practical Approach to Antibiotic Use in Critically Ill Obstetric Patients
inferred← citeshttps://doi.org/10.1097/cpm.0000000000000028openalex-snapshot
Macrolides to Prevent COPD Exacerbations
inferred← citeshttps://doi.org/10.1097/cpm.0000000000000041openalex-snapshot
Bronchiectasis
inferred← citeshttps://doi.org/10.1097/ipc.0000000000000984openalex-snapshot
Short-Course Azithromycin for Lower Respiratory Tract Infection in Adults
inferred← citeshttps://doi.org/10.1097/mcp.0000000000000017openalex-snapshot
Is there a role for macrolides in severe asthma?
inferred← citeshttps://doi.org/10.1097/mcp.0000000000000052openalex-snapshot
Community-acquired pneumonia
inferred← citeshttps://doi.org/10.1097/mcp.0000000000000261openalex-snapshot
Cardiovascular disease as a complication of community-acquired pneumonia
inferred← citeshttps://doi.org/10.1097/mjt.0000000000000138openalex-snapshot
Azithromycin and Risk of Cardiovascular Death
inferred← citeshttps://doi.org/10.1111/1755-5922.12054openalex-snapshot
Antibiotic‐induced Cardiac Arrhythmias
inferred← citeshttps://doi.org/10.1111/cea.70297openalex-snapshot
Association of Penicillin Allergy Label With Post‐ COVID ‐19 Condition and Subsequent Clinical Outcomes: A Population‐Based Cohort Study
inferred← citeshttps://doi.org/10.1111/cts.12867openalex-snapshot
The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin
inferred← citeshttps://doi.org/10.1111/ijd.12552openalex-snapshot
Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea
inferred← citeshttps://doi.org/10.1111/imj.15810openalex-snapshot
Appropriate prescribing of azithromycin for c ommunity‐acquired pneumonia
inferred← citeshttps://doi.org/10.1111/jcpt.12319openalex-snapshot
The role of azithromycin in healthcare-associated pneumonia treatment
inferred← citeshttps://doi.org/10.1111/nmo.13302openalex-snapshot
Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias
inferred← citeshttps://doi.org/10.1111/resp.12130openalex-snapshot
Effects of long‐term azithromycin therapy on airway oxidative stress markers in non‐cystic fibrosis bronchiectasis
inferred← citeshttps://doi.org/10.1111/tri.12579openalex-snapshot
Current views on chronic rejection after lung transplantation
inferred← citeshttps://doi.org/10.1128/aac.00438-18openalex-snapshot
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides
inferred← citeshttps://doi.org/10.1128/aac.03187-14openalex-snapshot
Maternal Intravenous Treatment with either Azithromycin or Solithromycin Clears Ureaplasma parvum from the Amniotic Fluid in an Ovine Model of Intrauterine Infection
inferred← citeshttps://doi.org/10.1128/aac.03721-14openalex-snapshot
Maternal Intravenous Administration of Azithromycin Results in Significant Fetal Uptake in a Sheep Model of Second Trimester Pregnancy
inferred← citeshttps://doi.org/10.1128/aac.03951-14openalex-snapshot
Pharmacokinetics, Microbial Response, and Pulmonary Outcomes of Multidose Intravenous Azithromycin in Preterm Infants at Risk for Ureaplasma Respiratory Colonization
inferred← citeshttps://doi.org/10.1128/mmbr.00013-14openalex-snapshot
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
inferred← citeshttps://doi.org/10.1128/msphere.00964-21openalex-snapshot
Optimizing Nanopore Sequencing for Rapid Detection of Microbial Species and Antimicrobial Resistance in Patients at Risk of Surgical Site Infections
inferred← citeshttps://doi.org/10.1136/bmj.g4930openalex-snapshot
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
inferred← citeshttps://doi.org/10.1136/bmj.g5237openalex-snapshot
Management and prevention of exacerbations of COPD
inferred← citeshttps://doi.org/10.1136/bmj.g6242openalex-snapshot
Antibiotics and sudden death in adults taking renin-angiotensin system blockers
inferred← citeshttps://doi.org/10.1136/bmj.h6926openalex-snapshot
Cardiovascular outcomes associated with use of clarithromycin: population based study
inferred← citeshttps://doi.org/10.1136/bmj.j.issn.1007-9742.2013.16.112openalex-snapshot
Azithromycin does not look cardiotoxic in a general population
inferred← citeshttps://doi.org/10.1136/bmj.k678openalex-snapshot
Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study
inferred← citeshttps://doi.org/10.1136/bmjopen-2017-019997openalex-snapshot
Does macrolide use confer risk of out-of-hospital cardiac arrest compared with penicillin V? A Danish national case-crossover and case–time–control study
inferred← citeshttps://doi.org/10.1136/bmjopen-2021-051579openalex-snapshot
Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study
inferred← citeshttps://doi.org/10.1136/bmjpo-2019-000469openalex-snapshot
Safety of azithromycin in paediatrics: a systematic review protocol
inferred← citeshttps://doi.org/10.1136/gutjnl-2017-314605openalex-snapshot
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori : a population-based study
inferred← citeshttps://doi.org/10.1136/thoraxjnl-2019-213929openalex-snapshot
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
inferred← citeshttps://doi.org/10.1136/thoraxjnl-2021-217962openalex-snapshot
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1139/cjpp-2019-0569openalex-snapshot
The effect of gender and ABCB1 gene polymorphism on the pharmacokinetics of azithromycin in healthy male and female Pakistani subjects
inferred← citeshttps://doi.org/10.1155/2018/1574806openalex-snapshot
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
inferred← citeshttps://doi.org/10.1159/000358443openalex-snapshot
Efficacy of Azithromycin for Treatment of Acute Exacerbation of Chronic Fibrosing Interstitial Pneumonia: A Prospective, Open-Label Study with Historical Controls
inferred← citeshttps://doi.org/10.1161/circresaha.119.315279openalex-snapshot
Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality
inferred← citeshttps://doi.org/10.1161/circresaha.119.316406openalex-snapshot
Use of Antibiotics and Mortality in Women
inferred← citeshttps://doi.org/10.1161/jaha.117.008074openalex-snapshot
Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities
inferred← citeshttps://doi.org/10.1161/jaha.122.028939openalex-snapshot
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
inferred← citeshttps://doi.org/10.1164/rccm.201402-0385ciopenalex-snapshot
Macrolide Antibiotics and the Risk of Cardiac Arrhythmias
inferred← citeshttps://doi.org/10.1164/rccm.201501-0044stopenalex-snapshot
An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1164/rccm.201606-1179ppopenalex-snapshot
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1164/rccm.202309-1699leopenalex-snapshot
Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin
inferred← citeshttps://doi.org/10.1177/0897190013516503openalex-snapshot
Azithromycin and the Risk of Cardiovascular Complications
inferred← citeshttps://doi.org/10.1177/08971900231213701openalex-snapshot
Effect of Intravenous Azithromycin on the QT Interval of ICU Patients
inferred← citeshttps://doi.org/10.1177/1060028013504905openalex-snapshot
Azithromycin-Induced Proarrhythmia and Cardiovascular Death
inferred← citeshttps://doi.org/10.1177/1753465816682677openalex-snapshot
Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1177/1753944717745493openalex-snapshot
Algorithms used to identify ventricular arrhythmias and sudden cardiac death in retrospective studies: a systematic literature review
inferred← citeshttps://doi.org/10.1177/2049936113501816openalex-snapshot
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes , and regulatory issues: A narrative review based on the study of case reports
inferred← citeshttps://doi.org/10.1177/2049936114527744openalex-snapshot
Erythromycin, QTc interval prolongation, and torsade de pointes : Case reports, major risk factors and illness severity
inferred← citeshttps://doi.org/10.1177/2515841418783622openalex-snapshot
An eye for azithromycin: review of the literature
inferred← citeshttps://doi.org/10.1183/09031936.00009015openalex-snapshot
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD
inferred← citeshttps://doi.org/10.1183/09031936.00107514openalex-snapshot
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome
inferred← citeshttps://doi.org/10.1183/13993003.01574-2024openalex-snapshot
Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasis
inferred← citeshttps://doi.org/10.1183/23120541.00786-2020openalex-snapshot
Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
inferred← citeshttps://doi.org/10.1183/2312508x.10004316openalex-snapshot
Antibiotics for pulmonary infections: an overview
inferred← citeshttps://doi.org/10.1183/2312508x.10005416openalex-snapshot
Long-term oral antibiotic treatment: why, what, when and to whom?
inferred← citeshttps://doi.org/10.1183/2312508x.10005516openalex-snapshot
Macrolide therapy for patients with pneumonia: a triple-edged sword
inferred← citeshttps://doi.org/10.1183/2312508x.10018814openalex-snapshot
Prophylactic antibiotics
inferred← citeshttps://doi.org/10.1183/2312508x.10028819openalex-snapshot
Cardiovascular side-effects of common antibiotics
inferred← citeshttps://doi.org/10.1186/2213-0802-1-13openalex-snapshot
Bacteria in COPD; their potential role and treatment
inferred← citeshttps://doi.org/10.1186/s12879-018-3630-7openalex-snapshot
Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial
inferred← citeshttps://doi.org/10.1186/s12911-016-0338-8openalex-snapshot
The eClinical Care Pathway Framework: a novel structure for creation of online complex clinical care pathways and its application in the management of sexually transmitted infections
inferred← citeshttps://doi.org/10.1186/s12912-025-03682-wopenalex-snapshot
Knowledge, attitude, and practice toward azithromycin infusion reactions among pediatric nurses: a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12931-017-0584-zopenalex-snapshot
Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides
inferred← citeshttps://doi.org/10.1186/s12931-020-01516-8openalex-snapshot
COVID-19 multidisciplinary high dependency unit: the Milan model
inferred← citeshttps://doi.org/10.1186/s13019-020-01299-5openalex-snapshot
COVID-19: an update and cardiac involvement
inferred← citeshttps://doi.org/10.1186/s41479-017-0025-2openalex-snapshot
Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study
inferred← citeshttps://doi.org/10.12746/swrccc.v2i5.107openalex-snapshot
Update on azithromycin and cardiac side effects
inferred← citeshttps://doi.org/10.1310/hpj5110-830openalex-snapshot
Impact of the FDA Warning for Azithromycin and Risk for QT Prolongation on Utilization at an Academic Medical Center
inferred← citeshttps://doi.org/10.1370/afm.1601openalex-snapshot
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
inferred← citeshttps://doi.org/10.1371/journal.pmed.1003372openalex-snapshot
Genetic and pharmacological relationship between P-glycoprotein and increased cardiovascular risk associated with clarithromycin prescription: An epidemiological and genomic population-based cohort study in Scotland, UK
inferred← citeshttps://doi.org/10.1371/journal.pone.0139097openalex-snapshot
Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals
inferred← citeshttps://doi.org/10.1503/cmaj.121573openalex-snapshot
Long-term macrolide therapy in chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1503/cmaj.140572openalex-snapshot
The cardiovascular safety of azithromycin
inferred← citeshttps://doi.org/10.1503/cmaj.150901openalex-snapshot
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults
inferred← citeshttps://doi.org/10.1503/cmaj.160355openalex-snapshot
Use of azithromycin and risk of ventricular arrhythmia
inferred← citeshttps://doi.org/10.1513/annalsats.201308-261cropenalex-snapshot
Macrolide Use Leads to Clinical and Radiological Improvement in Patients with Cryptogenic Organizing Pneumonia
inferred← citeshttps://doi.org/10.1513/annalsats.202004-309sdopenalex-snapshot
Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial
inferred← citeshttps://doi.org/10.1515/jtim-2015-0015openalex-snapshot
Current status and inspiration on macrolides in the treatment of chronic obstructive pulmonary disease
showing the first 200 of 239 · page through all 239
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.